Vanda Pharmaceuticals
VNDA
#7963
Rank
C$0.53 B
Marketcap
C$8.83
Share price
2.64%
Change (1 day)
32.81%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$57.85 Million a decrease over its 2023 earnings that were of -C$19.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion193.44%
2024 -C$57.85 Million191.43%
2023 -C$19.85 Million-320.45%
2022 C$9 M-84.99%
2021 C$59.98 M54.8%
2020 C$38.75 M19.42%
2019 C$32.44 M4.93%
2018 C$30.92 M-228.6%
2017 -C$24.05 Million-8.98%
2016 -C$26.42 Million-53.79%
2015 -C$57.17 Million-30.18%
2014 -C$81.88 Million173.08%
2013 -C$29.99 Million-25.33%
2012 -C$40.16 Million163.61%
2011 -C$15.24 Million-221.15%
2010 C$12.57 M-124.53%
2009 -C$51.26 Million-29.44%
2008 -C$72.65 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$93.48 Million170.55%
2005 -C$34.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.95 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.45 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$15.06 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.27 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.71 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.65 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$4 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA